These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


129 related items for PubMed ID: 17359293

  • 1. PTEN augments doxorubicin-induced apoptosis in PTEN-null Ishikawa cells.
    Wan X, Li J, Xie X, Lu W.
    Int J Gynecol Cancer; 2007; 17(4):808-12. PubMed ID: 17359293
    [Abstract] [Full Text] [Related]

  • 2. [Sensitivity of PTEN gene-transfected endometrial carcinoma cell line to doxorubicin-induced apoptosis].
    Wan XY, Mao YY, Yokoyama Y.
    Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):513-5. PubMed ID: 16438844
    [Abstract] [Full Text] [Related]

  • 3. PTEN augments staurosporine-induced apoptosis in PTEN-null Ishikawa cells by downregulating PI3K/Akt signaling pathway.
    Wan X, Yokoyama Y, Shinohara A, Takahashi Y, Tamaya T.
    Cell Death Differ; 2002 Apr; 9(4):414-20. PubMed ID: 11965494
    [Abstract] [Full Text] [Related]

  • 4. [Effect of signal transduction inhibitors on human endometrial carcinoma cells with differential PTEN gene expression].
    Xiao L, Yang YB, Shen HM, Xu CF, Wang XY, Li XM.
    Zhonghua Fu Chan Ke Za Zhi; 2009 Sep; 44(9):681-5. PubMed ID: 20079181
    [Abstract] [Full Text] [Related]

  • 5. [Effect of gonadotropin-releasing hormone-I agonist and gonadotropin-releasing hormone-II on endometrial carcinoma cell lines with different states of PTEN].
    Zhao LJ, Wei LH, Li XP, Wang JL.
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jan; 44(1):45-9. PubMed ID: 19563062
    [Abstract] [Full Text] [Related]

  • 6. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
    St-Germain ME, Gagnon V, Mathieu I, Parent S, Asselin E.
    Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356
    [Abstract] [Full Text] [Related]

  • 7. miR-205 inhibits cell growth by targeting AKT-mTOR signaling in progesterone-resistant endometrial cancer Ishikawa cells.
    Zhuo Z, Yu H.
    Oncotarget; 2017 Apr 25; 8(17):28042-28051. PubMed ID: 28427207
    [Abstract] [Full Text] [Related]

  • 8. Growth and activation of PI-3K/PKB and Akt by stromal cell-derived factor 1alpha in endometrial carcinoma cells with expression of suppressor endoprotein PTEN.
    Li XP, Zhao D, Gao M, Zhao C, Wang JL, Wei LH.
    Chin Med J (Engl); 2006 Mar 05; 119(5):378-83. PubMed ID: 16542580
    [Abstract] [Full Text] [Related]

  • 9. PTEN sensitizes epidermal growth factor-mediated proliferation in endometrial carcinoma cells.
    Tang LL, Yokoyama Y, Wan X, Iwagaki S, Niwa K, Tamaya T.
    Oncol Rep; 2006 Apr 05; 15(4):855-9. PubMed ID: 16525671
    [Abstract] [Full Text] [Related]

  • 10. EGFR- and AKT-mediated reduction in PTEN expression contributes to tyrphostin resistance and is reversed by mTOR inhibition in endometrial cancer cells.
    Li T, Yang Y, Li X, Xu C, Meng L.
    Mol Cell Biochem; 2012 Feb 05; 361(1-2):19-29. PubMed ID: 21952748
    [Abstract] [Full Text] [Related]

  • 11. Akt activity in endometrial cancer cells: regulation of cell survival through cIAP-1.
    Gagnon V, St-Germain ME, Parent S, Asselin E.
    Int J Oncol; 2003 Sep 05; 23(3):803-10. PubMed ID: 12888921
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth.
    Edwards LA, Thiessen B, Dragowska WH, Daynard T, Bally MB, Dedhar S.
    Oncogene; 2005 May 19; 24(22):3596-605. PubMed ID: 15782140
    [Abstract] [Full Text] [Related]

  • 13. Correlation between loss of PTEN expression and Akt phosphorylation in endometrial carcinoma.
    Kanamori Y, Kigawa J, Itamochi H, Shimada M, Takahashi M, Kamazawa S, Sato S, Akeshima R, Terakawa N.
    Clin Cancer Res; 2001 Apr 19; 7(4):892-5. PubMed ID: 11309338
    [Abstract] [Full Text] [Related]

  • 14. Differential sensitivity of human endometrial carcinoma cells with different PTEN expression to mitogen-activated protein kinase signaling inhibits and implications for therapy.
    Xiao L, Yang YB, Li XM, Xu CF, Li T, Wang XY.
    J Cancer Res Clin Oncol; 2010 Jul 19; 136(7):1089-99. PubMed ID: 20087603
    [Abstract] [Full Text] [Related]

  • 15. The PTEN tumor suppressor inhibits telomerase activity in endometrial cancer cells by decreasing hTERT mRNA levels.
    Zhou C, Bae-Jump VL, Whang YE, Gehrig PA, Boggess JF.
    Gynecol Oncol; 2006 May 19; 101(2):305-10. PubMed ID: 16380156
    [Abstract] [Full Text] [Related]

  • 16. Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappaB/IkappaB pathway.
    St-Germain ME, Gagnon V, Parent S, Asselin E.
    Mol Cancer; 2004 Mar 11; 3():7. PubMed ID: 15016316
    [Abstract] [Full Text] [Related]

  • 17. MiR-205 inhibits cell apoptosis by targeting phosphatase and tensin homolog deleted on chromosome ten in endometrial cancer Ishikawa cells.
    Zhang G, Hou X, Li Y, Zhao M.
    BMC Cancer; 2014 Jun 14; 14():440. PubMed ID: 24929707
    [Abstract] [Full Text] [Related]

  • 18. The effect of estrogen on the proliferation of endometrial cancer cells is mediated by ERRγ through AKT and ERK1/2.
    Sun Y, Wang C, Yang H, Ma X.
    Eur J Cancer Prev; 2014 Sep 14; 23(5):418-24. PubMed ID: 25068805
    [Abstract] [Full Text] [Related]

  • 19. Signal transduction pathways in Burkitt's lymphoma cell lines BL41 and DG75 with different sensitivity to doxorubicin.
    Shlapatska LM, Berdova GG, Kovalevska LM, Kulyk GI, Klein G, Sidorenko SP, Chekhun VF.
    Exp Oncol; 2004 Sep 14; 26(3):210-6. PubMed ID: 15494689
    [Abstract] [Full Text] [Related]

  • 20. Resistance to TRAIL-induced apoptosis caused by constitutional phosphorylation of Akt and PTEN in acute lymphoblastic leukemia cells.
    Dida F, Li Y, Iwao A, Deguchi T, Azuma E, Komada Y.
    Exp Hematol; 2008 Oct 14; 36(10):1343-53. PubMed ID: 18599181
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.